Abstract
Cryptococcus is an important opportunistic, pathogenic fungus that can infect both immunocompromised and immunocompetent individuals. The infection always involves the central nervous system (CNS), presenting as meningitis or meningoencephalitis. Cryptococcal infections of the lung also occur; however, these infections have been largely ignored because of the atypical clinical symptoms associated with them. Therefore, it is necessary to study Cryptococcus infections of the lung to gain a better understanding of the epidemiology, treatment and diagnosis of pulmonary cryptococcosis.
Keywords: Cryptococcus neoformans, Cryptococcus gattii, pneumonia.
Current Respiratory Medicine Reviews
Title:Pulmonary Cryptococcocal Infection
Volume: 8 Issue: 5
Author(s): Meng Li and Wanqing Liao
Affiliation:
Keywords: Cryptococcus neoformans, Cryptococcus gattii, pneumonia.
Abstract: Cryptococcus is an important opportunistic, pathogenic fungus that can infect both immunocompromised and immunocompetent individuals. The infection always involves the central nervous system (CNS), presenting as meningitis or meningoencephalitis. Cryptococcal infections of the lung also occur; however, these infections have been largely ignored because of the atypical clinical symptoms associated with them. Therefore, it is necessary to study Cryptococcus infections of the lung to gain a better understanding of the epidemiology, treatment and diagnosis of pulmonary cryptococcosis.
Export Options
About this article
Cite this article as:
Li Meng and Liao Wanqing, Pulmonary Cryptococcocal Infection, Current Respiratory Medicine Reviews 2012; 8 (5) . https://dx.doi.org/10.2174/157339812803832511
DOI https://dx.doi.org/10.2174/157339812803832511 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Effects of Soluble Aβ Oligomers on Neurodegeneration in Alzheimer's Disease
Current Pharmaceutical Design Therapeutic Advances in the Treatment of Alzheimer's Disease: Present and Future
Current Drug Therapy Immunotherapy for Alzheimers Disease: Rational Basis in Ongoing Clinical Trials
Current Pharmaceutical Design Exposure to Perinatal Infections and Bipolar Disorder: A Systematic Review
Current Molecular Medicine Immunopathological Aspects of Mycoplasma pneumoniae Infection
Current Pediatric Reviews Central Nervous System Vasculitis: Still More Questions than Answers
Current Neuropharmacology Pharmacological Treatment of Mild Cognitive Impairment as a Prodromal Syndrome of Alzheimer´s Disease
Current Neuropharmacology Arboviral Encephalitis and RNAi Treatment
Central Nervous System Agents in Medicinal Chemistry Efficacy and Toxicity of Clioquinol Treatment and A-beta42 Inoculation in the APP/PSI Mouse Model of Alzheimer's Disease
Current Alzheimer Research Uveitis in Rheumatic Diseases
Current Rheumatology Reviews Biotechnological Approaches for Control of Listeria monocytogenes in Foods
Current Biotechnology Immunotherapy for Conformational Diseases
Current Pharmaceutical Design Drug Targets from Human Pathogenic Amoebas: Entamoeba histolytica,Acanthamoeba polyphaga and Naegleria fowleri
Infectious Disorders - Drug Targets Therapeutic Approaches Targeting Pathological Tau Aggregates
Current Pharmaceutical Design West Nile Virus Vaccine.
Current Drug Targets - Infectious Disorders Targeting IL-23 and Th17-Cytokines in Inflammatory Bowel Diseases
Current Pharmaceutical Design How to Manage the Infectious Risk under Anti-TNF in Inflammatory Bowel Disease
Current Drug Targets Nanoparticle-Mediated Drug Delivery: Blood-Brain Barrier as the Main Obstacle to Treating Infectious Diseases in CNS
Current Pharmaceutical Design Herpetic (Non-Cytomegalovirus) Retinal Infections in Patients with the Acquired Immunodeficiency Syndrome
Current HIV Research The Role of Neurogenesis in Neurodegenerative Diseases and its Implications for Therapeutic Development
CNS & Neurological Disorders - Drug Targets